BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29648825)

  • 1. Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.
    Fournier JF; Clary L; Chambon S; Dumais L; Harris CS; Millois C; Pierre R; Talano S; Thoreau É; Aubert J; Aurelly M; Bouix-Peter C; Brethon A; Chantalat L; Christin O; Comino C; El-Bazbouz G; Ghilini AL; Isabet T; Lardy C; Luzy AP; Mathieu C; Mebrouk K; Orfila D; Pascau J; Reverse K; Roche D; Rodeschini V; Hennequin LF
    J Med Chem; 2018 May; 61(9):4030-4051. PubMed ID: 29648825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease.
    Mou J; Wu S; Luo Z; Guo F; He H; Wang J; Lin F; Guo F; Sun J; Shen L; Zeng M; Wang C; Xu D; Gu Z; Tian X; Zhang A; Xu H; Yang L; Zhang X; Li J; Chen S
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1874-1878. PubMed ID: 29650287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors.
    Patel S; Modi P; Ranjan V; Chhabria M
    Bioorg Chem; 2018 Aug; 78():258-268. PubMed ID: 29614437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.
    Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1.
    Kawarski M; Hagerman TK; Karver CE
    Chem Biol Drug Des; 2015 Nov; 86(5):1049-54. PubMed ID: 25871734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
    Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
    J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of caspase-1 inhibitors derived from Tethering.
    O'Brien T; Fahr BT; Sopko MM; Lam JW; Waal ND; Raimundo BC; Purkey HE; Pham P; Romanowski MJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 May; 61(Pt 5):451-8. PubMed ID: 16511067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis.
    Nastase MV; Zeng-Brouwers J; Frey H; Hsieh LT; Poluzzi C; Beckmann J; Schroeder N; Pfeilschifter J; Lopez-Mosqueda J; Mersmann J; Ikeda F; Iozzo RV; Dikic I; Schaefer L
    Am J Pathol; 2016 May; 186(5):1206-20. PubMed ID: 26968342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin.
    Burgy O; Bellaye PS; Causse S; Beltramo G; Wettstein G; Boutanquoi PM; Goirand F; Garrido C; Bonniaud P
    Respir Res; 2016 Nov; 17(1):162. PubMed ID: 27894300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.
    Zhao N; Zhuo X; Lu Y; Dong Y; Ahmed ME; Tucker D; Scott EL; Zhang Q
    Mol Neurobiol; 2017 Sep; 54(7):4936-4952. PubMed ID: 27520275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model.
    Fukatsu H; Koide N; Tada-Oikawa S; Izuoka K; Ikegami A; Ichihara S; Ukaji T; Morita N; Naiki Y; Komatsu T; Umezawa K
    Mol Med Rep; 2018 Dec; 18(6):5279-5285. PubMed ID: 30320338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturated fatty acids activate caspase-4/5 in human monocytes, triggering IL-1β and IL-18 release.
    Pillon NJ; Chan KL; Zhang S; Mejdani M; Jacobson MR; Ducos A; Bilan PJ; Niu W; Klip A
    Am J Physiol Endocrinol Metab; 2016 Nov; 311(5):E825-E835. PubMed ID: 27624102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying caspase-1 inhibitors for inflammasome assays in human whole blood.
    Lipinska K; Malone KE; Moerland M; Kluft C
    J Immunol Methods; 2014 Sep; 411():66-9. PubMed ID: 24925806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment.
    Caruso F; Pedersen JZ; Incerpi S; Kaur S; Belli S; Florea RM; Rossi M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
    Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical retinoyl beta-glucuronide is an effective treatment of mild to moderate acne vulgaris in Asian-Indian patients.
    Goswami BC; Baishya B; Barua AB; Olson JA
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):167-73. PubMed ID: 10420136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fused Bicyclic Caspase-1 Inhibitors Assembled by Copper-Free Strain-Promoted Alkyne-Azide Cycloaddition (SPAAC).
    Qian L; Zhang CJ; Wu J; Yao SQ
    Chemistry; 2017 Jan; 23(2):360-369. PubMed ID: 27882694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malonate-assisted purification of human caspases.
    Scheer JM; Wells JA; Romanowski MJ
    Protein Expr Purif; 2005 May; 41(1):148-53. PubMed ID: 15802232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylate isosteres for caspase inhibitors: the acylsulfonamide case revisited.
    Adriaenssens Y; Jiménez Fernández D; Vande Walle L; Elvas F; Joossens J; Lambeir A; Augustyns K; Lamkanfi M; Van der Veken P
    Org Biomol Chem; 2017 Sep; 15(35):7456-7473. PubMed ID: 28837200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.